Projects funded by the NCN
New positive allosteric modulators of EAAT2 glutamate transporter as candidates for treatment of neurological and psychiatric diseases
2022/45/B/NZ7/00598
Keywords:
EAAT2 transporter positive allosteric modulators (PAMs) synthesis in vivo studies in vitro studies anti-seizure activity neuroprotective activity
Descriptors:
- NZ7_14: Pharmacy, pharmacotherapy, pharmacology
Panel:
NZ7 - Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology
Host institution :
Uniwersytet Jagielloński, Collegium Medicum
woj. małopolskie
Principal investigator (from the host institution):
Number of co-investigators in the project: 20
Call: OPUS 23 - announced on 2022-03-28
Amount awarded: 2 884 054 PLN
Project start date (Y-m-d): 2023-02-07
Project end date (Y-m-d): 2027-02-06
Project duration:: 48 months (the same as in the proposal)
Project status: Pending project
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.